Global Retirement Partners’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,100
Closed -$26.2K – 4920
2026
Q2
$26.2K Buy
+1,100
New +$24.5K ﹤0.01% 2902
2025
Q4
$42.8K Hold
1,100
– – ﹤0.01% 2447
2025
Q3
$25K Sell
1,100
-63
-5% -$1.28K ﹤0.01% 2289
2025
Q2
$23.7K Buy
+1,163
New +$21.5K ﹤0.01% 2201
2024
Q4
$29.3K Hold
1,100
– – ﹤0.01% 1873
2024
Q3
$31.4K Hold
1,100
– – ﹤0.01% 1776
2024
Q2
$23.9K Hold
1,100
– – ﹤0.01% 1890
2024
Q1
$24.4K Sell
1,100
-5
-0.5% -$109 ﹤0.01% 1726
2023
Q4
$21.4K Buy
1,105
+1,078
+3,993% +$19K ﹤0.01% 1726
2023
Q3
$416 Hold
27
– – ﹤0.01% 3001
2023
Q2
$370 Hold
27
– – ﹤0.01% 3012
2023
Q1
$619 Sell
27
-50
-65% -$1.22K ﹤0.01% 2875
2022
Q4
$1.81K Hold
77
– – ﹤0.01% 2392
2022
Q3
$2K Hold
77
– – ﹤0.01% 2214
2022
Q2
$2K Hold
77
– – ﹤0.01% 2175
2022
Q1
$2K Buy
77
+27
+54% +$1.12K ﹤0.01% 2159
2021
Q4
$2K Hold
50
– – ﹤0.01% 215
2021
Q3
$3K Hold
50
– – ﹤0.01% 1740
2021
Q2
$4K Hold
50
– – ﹤0.01% 1614
2021
Q1
$3K Sell
50
-331
-87% -$24.9K ﹤0.01% 1574
2020
Q4
$26K Hold
381
– – ﹤0.01% 950
2020
Q3
$20K Buy
381
+180
+90% +$8.01K ﹤0.01% 922
2020
Q2
$8K Hold
201
– – ﹤0.01% 1161
2020
Q1
$6K Sell
201
-900
-82% -$27.2K ﹤0.01% 1160
2019
Q4
$38K Buy
+1,101
New +$26.9K 0.01% 708

Other funds holding CSTL

Global Retirement Partners's CSTL Position: Q3 2026 in Review

Global Retirement Partners sold out of Castle Biosciences (CSTL) in Q3 2026, closing a stake of 1,100 shares — an estimated $26.2K sold.

Global Retirement Partners first reported a position in CSTL in Q4 2019 and held it in 25 quarters. The position peaked at $42.8K in Q4 2025. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Global Retirement Partners reported no remaining Castle Biosciences position as of Q3 2026 after selling out during the quarter.
  • Global Retirement Partners sold 1,100 Castle Biosciences shares in Q3 2026, an estimated $26.2K.
  • Global Retirement Partners first reported a position in Castle Biosciences in Q4 2019 and held it in 25 quarters.
  • Global Retirement Partners's Castle Biosciences position peaked at $42.8K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.